SEC Form 4 · accession 0001053369-15-000022
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ashok G Nigalaye
Director
Period of report
Apr 23, 2015
Accepted (ET)
Apr 27, 2015 · 6:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 23, 2015 | J | 67,659,232 | $0.00 | D | 0 | I | BY Epic Investments, LLC |
| Common StockF3 | Apr 23, 2015 | J | 19,275,133 | $0.00 | A | 55,717,363 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition of common stock to its members.
- F2Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI")(which is controlled by EP), which was a 10% owner of the issuer, and also serves as a director of the issuer.
- F3Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which was a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.